Lentiviral vectors: Progress and potential

Current Opinion in Molecular Therapeutics

Volumn 2, Issue 5, 2000, Pages 488-496

  Lever, A M L ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Gene therapy; Lentivirus vector; Non mitotic cell

Indexed keywords

VIRUS VECTOR;

CELL LINE; CHROMOSOME; GENE TARGETING; GENE THERAPY; GENETIC TRANSDUCTION; HUMAN IMMUNODEFICIENCY VIRUS; LENTIVIRINAE; NONHUMAN; REVIEW; RNA PROCESSING; VIRUS STRAIN;

ANIMALS; CELL LINE; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; INTERPHASE; LENTIVIRUS; ORGAN SPECIFICITY; TRANSDUCTION, GENETIC;

EID: 0033753061     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Lentiviral vectors - The promise of gene therapy within reach?
2. Lentiviral vectors: Turning a deadly foe into a therapeutic agent
3. Lentiviral vectors
4. Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity
5. Gene transfer into human lymphocytes by a defective human immunodeficiency virus type 1 vector
6. Pseudotyping with human T-cell leukemia virus type 1 broadens the human immunodeficiency virus host range
7. High-efficiency gene transfer into CD34(+) cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G
8. In vivo gene delivery and stable transduction of non-dividing cells by a lentiviral vector
9. Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A
10. Interaction of vesicular stomatitis virus-G pseudotyped retrovirus with CD34+ and CD34+ CD38- hematopoietic progenitor cells
11. Cytokine signals are sufficient for HIV-1 infection of resting human T-lymphocytes
12. Transduction of human progenitor hematopoietic stem cells by human immunodeficiency virus type 1-based vectors is cell cycle dependent
13. Modified human immunodeficiency virus-based lentiviral vectors display decreased sensitivity to trans-dominant Rev
14. Self-inactivating lentiviral vectors with enhanced transgene expression and potential gene transfer system in Parkinsons's disease
15. A lentivirus packaging system based on alternative RNA transport mechanisms to express helper and gene transfer vector RNAs and its use to study the requirement of accessory proteins for particle formation and gene delivery
16. Gene transfer to human pancreatic endocrine cells using viral vectors
17. Infection of intact human islets by a lentiviral vector
18. Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis
19. Lentivirus-mediated Bcl-2 expression In βTC-tet cells improves resistance to hypoxia and cytokine-induced apoptosis while preserving in vitro and in vivo control of insulin secretion
20. Efficient and sustained transgene expression in human corneal cells mediated by a lentiviral vector
21. Stable and efficient gene transfer into the mutant retinal pigment epithelial cells of the Mitf(vit) mouse using a lentiviral vector
22. Rescue from photoreceptor degeneration in the rd mouse by human immunodeficiency virus vector-mediated gene transfer
23. Lentiviral gene transfer to the non-human primate brain
24. In vivo protection of nigral dopamine neurons by lentiviral gene transfer of the novel GDNF-family member neublastin/artemin
25. A high-titer lentiviral production system mediates efficient transduction of differentiated cells including beating cardiac myocytes
26. Infection of human fetal cardiac myocytes by a human immunodeficiency virus-1-derived vector
27. Transgene expression in the guinea pig cochlea mediated by a lentivirus-derived gene transfer vector
28. Gene delivery to human B-precursor acute lymphoblastic leukemia cells
29. Efficient lentiviral transduction of liver requires cell cycling in vivo
30. A packaging cell line for lentivirus vectors
31. HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure
32. Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors
33. Human cord blood CD34+/CD38- cell transduction via lentivirus-based gene transfer vectors
34. Marking and gene expression by a lentivirus vector in transplanted human and non-human primate CD34(+) cells
35. Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors
36. Human immunodeficiency virus type 1 vectors efficiently transduce human hematopoietic stem cells
37. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery
38. Development of a self-inactivating lentivirus vector
39. Self-inactivating lentiviral vectors with U3 and U5 modifications
40. Development of self-inactivating, minimal lentivirus vector based on simian immunodeficiency virus
41. Location of cis-acting signals important for RNA encapsidation in the leader sequence of human immunodeficiency virus type 2
42. Human immunodeficiency virus type 2 lentivirus vectors for gene transfer: Expression and potential for helper virus-free packaging
43. Identification of a human immunodeficiency virus type 2 (HIV-2) encapsidation determinant and transduction of non-dividing human cells by HIV-2-based lentivirus vectors
44. Human immunodeficiency virus types 1 and 2 differ in the predominant mechanism for selection of genomic RNA for encapsidation
45. Non-reciprocal packaging of human immunodeficiency virus type 1 and type 2 RNA: A possible role for the p2 domain of Gag in RNA encapsidation
46. Lentivirus vectors using human and simian immunodeficiency virus elements
47. Gene transfer vectors derived from equine infectious anemia virus
48. Stable gene transfer to the nervous system using a non-primate lentiviral vector
49. Feline immunodeficiency virus vectors persistently transduce non-dividing airway epithella and correct the cystic fibrosis defect
50. Pseudotyped human lentiviral vector-mediated gene transfer to airway epithelia in vivo
51. Lentiviral and murine retroviral transduction of T-cells for expression of human CD40 ligand
52. Gene transfer into stimulated and unstimulated T-lymphocytes by HIV-1-derived lentiviral vectors
53. A murine leukemia virus (MuLV) long terminal repeat derived from rhesus macaques in the context of a lentivirus vector and MuLV gag sequence results in high-level gene expression in human T-lymphocytes
54. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors
55. Contributions of viral splice sites and cis-regulatory elements to lentivirus vector function
56. Packaging of human immunodeficiency virus type 1 RNA requires cis-acting sequences outside the 5' reader region
57. Functional analysis of the core human immunodeficiency virus type 1 packaging signal in a permissive cell line